Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Fouque

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Toxins|April 27, 2023
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney DiseaseCarolla El Chamieh, Islam Amine Larabi, Solène M Laville, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2019
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTAPantelis Sarafidis, Charles J Ferro, Enrique Morales, et al.
Nature Reviews. Nephrology|June 13, 2020
Plant-based diets to manage the risks and complications of chronic kidney diseaseJuan J Carrero, Ailema González-Ortiz, Carla M Avesani, et al.
Journal of Cellular Physiology|January 21, 2026
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney DiseaseNajwa Skafi, Solenne Pelletier, Christophe O Soulage, et al.
Kidney International Reports|August 15, 2025
Association of Phenylacetylglutamine and Cognitive Impairment in CKDHélène Levassort, Julie Boucquemont, Sophie Liabeuf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Serum sclerostin: relation with mortality and impact of hemodiafiltrationLotte Lips, Camiel L M de Roij van Zuijdewijn, Piet M Ter Wee, et al.
Lancet (London, England)|November 5, 2015
The double challenge of resistant hypertension and chronic kidney diseasePatrick Rossignol, Ziad A Massy, Michel Azizi, et al.
Clinical Nutrition ESPEN|February 15, 2026
Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: a systematic review and meta-analysisCarolyn Blair, Adrian Slee, Clare McKeaveney, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2017
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and MetabolismBrandon M Kistler, Debbie Benner, Jerrilynn D Burrowes, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Toxins|April 27, 2023
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney DiseaseCarolla El Chamieh, Islam Amine Larabi, Solène M Laville, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2019
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTAPantelis Sarafidis, Charles J Ferro, Enrique Morales, et al.
Nature Reviews. Nephrology|June 13, 2020
Plant-based diets to manage the risks and complications of chronic kidney diseaseJuan J Carrero, Ailema González-Ortiz, Carla M Avesani, et al.
Journal of Cellular Physiology|January 21, 2026
Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney DiseaseNajwa Skafi, Solenne Pelletier, Christophe O Soulage, et al.
Kidney International Reports|August 15, 2025
Association of Phenylacetylglutamine and Cognitive Impairment in CKDHélène Levassort, Julie Boucquemont, Sophie Liabeuf, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 11, 2023
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKDSolène M Laville, Valérie Gras-Champel, Aghilès Hamroun, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Serum sclerostin: relation with mortality and impact of hemodiafiltrationLotte Lips, Camiel L M de Roij van Zuijdewijn, Piet M Ter Wee, et al.
Lancet (London, England)|November 5, 2015
The double challenge of resistant hypertension and chronic kidney diseasePatrick Rossignol, Ziad A Massy, Michel Azizi, et al.
Clinical Nutrition ESPEN|February 15, 2026
Anti-inflammatory effects and safety of omega-3 fatty acids in haemodialysis: a systematic review and meta-analysisCarolyn Blair, Adrian Slee, Clare McKeaveney, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 19, 2017
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and MetabolismBrandon M Kistler, Debbie Benner, Jerrilynn D Burrowes, et al.
Pageof 31